Pharma Mar, S.A. (PHM.MC)

EUR 76.95

(0.59%)

Operating Expenses Summary of Pharma Mar, S.A.

  • Pharma Mar, S.A.'s latest annual operating expenses in 2023 was 152.36 Million EUR , up 8.64% from previous year.
  • Pharma Mar, S.A.'s latest quarterly operating expenses in 2024 Q3 was 38.18 Million EUR , down -5.78% from previous quarter.
  • Pharma Mar, S.A. reported a annual operating expenses of 138.26 Million EUR in annual operating expenses 2022, up 14.23% from previous year.
  • Pharma Mar, S.A. reported a annual operating expenses of 121.04 Million EUR in annual operating expenses 2021, up 21.0% from previous year.
  • Pharma Mar, S.A. reported a quarterly operating expenses of 40.53 Million EUR for 2024 Q1, down -6.26% from previous quarter.
  • Pharma Mar, S.A. reported a quarterly operating expenses of 38.18 Million EUR for 2024 Q3, down -5.78% from previous quarter.

Annual Operating Expenses Chart of Pharma Mar, S.A. (2023 - 2002)

Historical Annual Operating Expenses of Pharma Mar, S.A. (2023 - 2002)

Year Operating Expenses Operating Expenses Growth
2023 152.36 Million EUR 8.64%
2022 138.26 Million EUR 14.23%
2021 121.04 Million EUR 21.0%
2020 100.03 Million EUR 2.0%
2019 98.06 Million EUR -30.18%
2018 140.44 Million EUR -7.2%
2017 151.35 Million EUR -2.78%
2016 155.67 Million EUR 14.65%
2015 135.78 Million EUR 44.97%
2014 93.66 Million EUR 6.43%
2013 88 Million EUR 0.84%
2012 87.27 Million EUR -17.2%
2011 105.4 Million EUR -9.92%
2010 117.01 Million EUR 4.75%
2009 111.7 Million EUR 8.22%
2008 103.22 Million EUR 11.51%
2007 92.57 Million EUR 1.9%
2006 90.84 Million EUR 924.44%
2005 8.86 Million EUR -5.36%
2004 9.37 Million EUR -86.52%
2003 69.52 Million EUR -9.91%
2002 77.18 Million EUR 0.0%

Peer Operating Expenses Comparison of Pharma Mar, S.A.

Name Operating Expenses Operating Expenses Difference
Atrys Health, S.A. 143.61 Million EUR -6.095%
Biotechnologies Assets SA 840.45 Thousand EUR -18029.216%
Laboratorios Farmaceuticos Rovi, S.A. 263.09 Million EUR 42.086%